A. Sinclair Dunlop, Director at Apellis Pharmaceuticals, Inc. (APLS), sold 24,000 shares at $49.00 ($1.2M) on 2023-10-17, disclosed to the SEC on 2023-11-21.
Open-market sale of $1.2M APLS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| APLS | SELL | 2025-09-19 | $1.4M | — | Filing → |
| APLS | SELL | 2024-09-17 | $2.7M | — | Filing → |
| APLS | SELL | 2024-06-21 | $2.9M | — | Filing → |